Ahlke Heydemann

3.0k total citations
63 papers, 2.4k citations indexed

About

Ahlke Heydemann is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ahlke Heydemann has authored 63 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 15 papers in Surgery and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ahlke Heydemann's work include Muscle Physiology and Disorders (38 papers), Tissue Engineering and Regenerative Medicine (10 papers) and Cardiomyopathy and Myosin Studies (9 papers). Ahlke Heydemann is often cited by papers focused on Muscle Physiology and Disorders (38 papers), Tissue Engineering and Regenerative Medicine (10 papers) and Cardiomyopathy and Myosin Studies (9 papers). Ahlke Heydemann collaborates with scholars based in United States, Poland and Russia. Ahlke Heydemann's co-authors include Elizabeth M. McNally, Mark E. Bolander, Michele Hadhazy, R. Tracy Ballock, Kathleen C. Flanders, Lalage M. Wakefield, Michael B. Sporn, Anita B. Roberts, Abraham A. Palmer and Jill M. Huber and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Ahlke Heydemann

61 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahlke Heydemann United States 27 1.6k 456 332 330 326 63 2.4k
Daisuke Taura Japan 24 968 0.6× 408 0.9× 277 0.8× 241 0.7× 294 0.9× 59 2.2k
Yee Sook Cho South Korea 29 1.9k 1.2× 577 1.3× 198 0.6× 391 1.2× 127 0.4× 66 3.1k
Elisabetta Gazzerro Italy 28 2.4k 1.5× 287 0.6× 298 0.9× 154 0.5× 406 1.2× 52 3.5k
Manisha Sinha India 15 2.1k 1.4× 492 1.1× 575 1.7× 156 0.5× 304 0.9× 41 3.3k
Foteini Mourkioti United States 22 2.2k 1.4× 525 1.2× 871 2.6× 224 0.7× 151 0.5× 38 3.3k
Michelle Wehling‐Henricks United States 23 1.8k 1.1× 370 0.8× 755 2.3× 203 0.6× 101 0.3× 32 2.5k
Massimiliano Cerletti United States 16 1.9k 1.2× 521 1.1× 1.1k 3.2× 194 0.6× 183 0.6× 20 3.4k
Shunsuke Uehara Japan 23 1.8k 1.1× 310 0.7× 150 0.5× 126 0.4× 315 1.0× 52 2.7k
Helge Amthor France 25 2.8k 1.8× 358 0.8× 743 2.2× 345 1.0× 179 0.5× 57 3.3k
Roberta Morosetti Italy 31 1.9k 1.2× 554 1.2× 182 0.5× 295 0.9× 99 0.3× 73 3.3k

Countries citing papers authored by Ahlke Heydemann

Since Specialization
Citations

This map shows the geographic impact of Ahlke Heydemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahlke Heydemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahlke Heydemann more than expected).

Fields of papers citing papers by Ahlke Heydemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahlke Heydemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahlke Heydemann. The network helps show where Ahlke Heydemann may publish in the future.

Co-authorship network of co-authors of Ahlke Heydemann

This figure shows the co-authorship network connecting the top 25 collaborators of Ahlke Heydemann. A scholar is included among the top collaborators of Ahlke Heydemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahlke Heydemann. Ahlke Heydemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carley, Andrew N., S. Maurya, Chandan K. Maurya, et al.. (2025). CPT1a Expression Is a Critical Cardioprotective Response to Pathological Stress That Enables Rescue by Gene Transfer. Circulation Research. 138(2). e327403–e327403.
2.
Heydemann, Ahlke, et al.. (2023). Dystrophin Expressing Chimeric (DEC) Cell Therapy for Duchenne Muscular Dystrophy: A First-in-Human Study with Minimum 6 Months Follow-up. Stem Cell Reviews and Reports. 19(5). 1340–1359. 11 indexed citations
3.
Heydemann, Ahlke, et al.. (2023). The MRL Mitochondrial Genome Decreases Murine Muscular Dystrophy Severity. SHILAP Revista de lepidopterología. 2(1). 37–50. 1 indexed citations
4.
Heydemann, Ahlke & Maria Siemionow. (2023). A Brief Review of Duchenne Muscular Dystrophy Treatment Options, with an Emphasis on Two Novel Strategies. Biomedicines. 11(3). 830–830. 11 indexed citations
5.
6.
Siemionow, Maria, et al.. (2023). Safety and Efficacy of DT-DEC01 Therapy in Duchenne Muscular Dystrophy Patients: A 12 - Month Follow-Up Study After Systemic Intraosseous Administration. Stem Cell Reviews and Reports. 19(8). 2724–2740. 8 indexed citations
7.
Siemionow, Maria, et al.. (2022). Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model. Archivum Immunologiae et Therapiae Experimentalis. 70(1). 20–20. 8 indexed citations
8.
Siemionow, Maria, Joanna Cwykiel, Anna Domaszewska-Szostek, et al.. (2020). Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model. Stem Cells and Development. 30(4). 190–202. 12 indexed citations
9.
Siemionow, Maria, et al.. (2018). Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy. Stem Cell Reviews and Reports. 14(2). 189–199. 30 indexed citations
10.
Urao, Norifumi, Rita E. Mirza, Ahlke Heydemann, Jesús Garcı́a, & Timothy J. Koh. (2016). Thrombospondin-1 levels correlate with macrophage activity and disease progression in dysferlin deficient mice. Neuromuscular Disorders. 26(3). 240–251. 16 indexed citations
11.
Heydemann, Ahlke. (2012). The super super-healing MRL mouse strain. Frontiers in Biology. 7(6). 522–538. 66 indexed citations
12.
Bowman, Marion A. Hofmann, Ahlke Heydemann, Joseph Gawdzik, Rebecca A. Shilling, & Blanca Camoretti-Mercado. (2011). Transgenic expression of human S100A12 induces structural airway abnormalities and limited lung inflammation in a mouse model of allergic inflammation. Clinical & Experimental Allergy. 41(6). 878–889. 29 indexed citations
13.
Heydemann, Ahlke, Ermelinda Ceco, Jackie E. Lim, et al.. (2010). Latent TGF-β–binding protein 4 modifies muscular dystrophy in mice. Journal of Clinical Investigation. 120(2). 645–645. 5 indexed citations
14.
Allikian, Michael J., Gira Bhabha, Ahlke Heydemann, et al.. (2007). Reduced life span with heart and muscle dysfunction in Drosophila sarcoglycan mutants. Human Molecular Genetics. 16(23). 2933–2943. 56 indexed citations
15.
Heydemann, Ahlke, Jill M. Huber, Alexis R. Demonbreun, Michele Hadhazy, & Elizabeth M. McNally. (2005). Genetic background influences muscular dystrophy. Neuromuscular Disorders. 15(9-10). 601–609. 73 indexed citations
16.
Lapidos, Karen A., Y. Erin Chen, Judy U. Earley, et al.. (2004). Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle. Journal of Clinical Investigation. 114(11). 1577–1585. 71 indexed citations
17.
Wheeler, Matthew T., Michael J. Allikian, Ahlke Heydemann, et al.. (2004). Smooth muscle cell–extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomyopathy. Journal of Clinical Investigation. 113(5). 668–675. 55 indexed citations
18.
Wheeler, Matthew T., Michael J. Allikian, Ahlke Heydemann, & Elizabeth M. McNally. (2002). The Sarcoglycan Complex in Striated and Vascular Smooth Muscle. Cold Spring Harbor Symposia on Quantitative Biology. 67(0). 389–398. 14 indexed citations
19.
Heydemann, Ahlke, Matthew T. Wheeler, & Elizabeth M. McNally. (2001). Cardiomyopathy in animal models of muscular dystrophy. Current Opinion in Cardiology. 16(3). 211–217. 16 indexed citations
20.
Jingushi, Seiya, et al.. (1990). Acidic fibroblast growth factor (aFGF) injection stimulates cartilage enlargement and inhibits cartilage gene expression in rat fracture healing. Journal of Orthopaedic Research®. 8(3). 364–371. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daisuke Taura Breakdown of academic impact, for papers by Yee Sook Cho Breakdown of academic impact, for papers by Elisabetta Gazzerro Breakdown of academic impact, for papers by Manisha Sinha Breakdown of academic impact, for papers by Foteini Mourkioti Breakdown of academic impact, for papers by Michelle Wehling‐Henricks Breakdown of academic impact, for papers by Massimiliano Cerletti Breakdown of academic impact, for papers by Shunsuke Uehara Breakdown of academic impact, for papers by Helge Amthor Breakdown of academic impact, for papers by Roberta Morosetti
Rankless by CCL
2026